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INT ROD UCT ION
Neutrophils are major players in innate immunity. They are 
recruited from circulation to infected tissues in response to 
infection, where they phagocytose and clear invading bacte-
rial and fungal pathogens. However, excessive accumulation 
or hyperactivation of neutrophils can also be detrimen-
tal to the host. Hence, neutrophil homeostasis, recruitment, 
and function need exquisite regulation (Christopher and 
Link, 2007; von Vietinghoff and Ley, 2008; Strydom and 
Rankin, 2013; Bardoel et al., 2014; Nauseef and Borregaard, 
2014; Kruger et al., 2015).
Leukocytes, including neutrophils, arise from self-re-
newing hematopoietic stem cells that produce differentiated 
lineage-committed progenitors. Granulocyte/macrophage 
progenitors produce neutrophils via a series of developmental 
stages: first as myoblast, promyelocytes, myelocytes, metamy-
elocytes (at which point cell division ceases), and band neu-
trophils and then mature segmented neutrophils (Kondo et 
al., 2003). Neutrophils remain in the BM for 5–6 d after the 
last granulocyte precursor division, and consequently, the BM 
is the main site of neutrophil reserves. During acute infection 
and inflammation, large numbers of neutrophils are recruited 
to affected tissues, and mature neutrophils are mobilized from 
Cytokine-induced neutrophil mobilization from the bone marrow to circulation is a critical event in acute inflammation, but 
how it is accurately controlled remains poorly understood. In this study, we report that CXCR2 ligands are responsible for rapid 
neutrophil mobilization during early-stage acute inflammation. Nevertheless, although serum CXCR2 ligand concentrations 
increased during inflammation, neutrophil mobilization slowed after an initial acute fast phase, suggesting a suppression of 
neutrophil response to CXCR2 ligands after the acute phase. We demonstrate that granulocyte colony-stimulating factor 
(G-CSF), usually considered a prototypical neutrophil-mobilizing cytokine, was expressed later in the acute inflammatory 
response and unexpectedly impeded CXCR2-induced neutrophil mobilization by negatively regulating CXCR2-mediated intra-
cellular signaling. Blocking G-CSF in vivo paradoxically elevated peripheral blood neutrophil counts in mice injected intraper-
itoneally with Escherichia coli and sequestered large numbers of neutrophils in the lungs, leading to sterile pulmonary 
inflammation. In a lipopolysaccharide-induced acute lung injury model, the homeostatic imbalance caused by G-CSF blockade 
enhanced neutrophil accumulation, edema, and inflammation in the lungs and ultimately led to significant lung damage. Thus, 
physiologically produced G-CSF not only acts as a neutrophil mobilizer at the relatively late stage of acute inflammation, but 
also prevents exaggerated neutrophil mobilization and the associated inflammation-induced tissue damage during early-phase 
infection and inflammation.
G-CSF maintains controlled neutrophil mobilization 
during acute inflammation by negatively regulating 
CXCR2 signaling
Besnik Bajrami,1,2,3* Haiyan Zhu,4* Hyun-Jeong Kwak,1,2,3 Subhanjan Mondal,1,2,3 Qingming Hou,1,2,3 
Guangfeng Geng,4 Kutay Karatepe,1,2,3 Yu C. Zhang,1,2,3 César Nombela-Arrieta,1,2,3,5 
Shin-Young Park,1,2,3 Fabien Loison,1,2,3 Jiro Sakai,1,2,3 Yuanfu Xu,4 Leslie E. Silberstein,1,2,3 and 
Hongbo R. Luo1,2,3
1Department of Pathology, Harvard Medical School, Boston, MA 02115
2Department of Lab Medicine, The Stem Cell Program, Joint Program in Transfusion Medicine, Children’s Hospital Boston, Boston, MA 02115
3Dana-Farber/Harvard Cancer Center, Boston, MA 02115
4The State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Center for Stem Cell Medicine, Chinese Academy of 
Medical Sciences and Peking Union Medical College, Tianjin 300020, China
5Department of Experimental Hematology, University Hospital Zurich, 8091 Zurich, Switzerland
© 2016 Bajrami et al. This article is distributed under the terms of an Attribution–Noncommercial–Share 
Alike–No Mirror Sites license for the first six months after the publication date (see http ://www .rupress .org 
/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–
Share Alike 3.0 Unported license, as described at http ://creativecommons .org /licenses /by -nc -sa /3 .0 /).
*B. Bajrami and H. Zhu contributed equally to this paper.
Correspondence to Hongbo R. Luo: Hongbo.Luo@childrens.harvard.edu
F. Loison’s present address is Dept. of Microbiology, Faculty of Science, Mahidol Uni-
versity, Bangkok 10400, Thailand.
Abbreviations used: BAL, bronchoalveolar lavage; BALF, BAL fluid; eGFP, enhanced 
GFP; G-CSF, granulocyte CSF; IVM, intravital microscopy; KC, keratinocyte chemo-
attractant; MACS, magnetic-activated cell sorting; MP-IVM, multiphoton IVM; PB, 
peripheral blood; PMN, polymorphonuclear neutrophil.
T
h
e 
Jo
u
rn
al
 o
f 
E
xp
er
im
en
ta
l 
M
ed
ic
in
e
o
n
 February 8, 2017
D
ow
nloaded from
 
Published August 22, 2016
/content/suppl/2016/08/18/jem.20160393.DC1.html 
Supplemental Material can be found at:
Negative regulation of CXCR2 signaling by G-CSF | Bajrami et al.2000
the BM to peripheral blood (PB) to compensate for their 
peripheral loss. This transient neutrophilia ensures that neu-
trophils are rapidly delivered to sites of infection.
The regulation of neutrophil and progenitor cell mo-
bilization during acute inflammation has been extensively 
studied (Furze and Rankin, 2008; Sadik et al., 2011; Day 
and Link, 2012). Granulocyte CSF (G-CSF) is a prototypical 
neutrophil-mobilizing cytokine under both basal and stress 
conditions (Petit et al., 2002; Semerad et al., 2002; Brox-
meyer, 2008; Knudsen et al., 2011; Dale, 2012; Bendall and 
Bradstock, 2014). After a single G-CSF injection, PB neu-
trophil numbers increase significantly, peak at 6 h, and return 
to near-baseline levels by 24 h (Lévesque et al., 2003; Sem-
erad et al., 2005; Kim et al., 2006; De La Luz Sierra et al., 
2007). G-CSF is also a hematopoietic cytokine and has mul-
tiple functions in normal, steady-state hematopoiesis includ-
ing the regulation of neutrophil progenitor proliferation and 
differentiation and the functional activation of neutrophils 
(Gregory et al., 2007). Several other neutrophil-mobilizing 
agents are thought to contribute to stress-induced mobili-
zation, the most notable being C5a, leukotriene B4 (LTB4), 
and CXCR2 ligands (e.g., IL-8 in humans and keratinocyte 
chemoattractant [KC] and macrophage inflammatory protein 
2 [MIP-2] in mice; Martin et al., 2003; Burdon et al., 2005; 
Eash et al., 2010). CXCR2 ligand–induced neutrophil mobi-
lization is much quicker than G-CSF–induced mobilization, 
with 10-fold neutrophilia occurring 30 min after injection 
(Fibbe et al., 1999). The rapidity of CXCR2-induced mobi-
lization (minutes to hours) compared with G-CSF (hours to 
days) suggests that there are distinct mobilization mechanisms. 
Similar effects have also been seen in G-CSF– and CXCR2 
ligand–induced mobilization of hematopoietic stem/progen-
itor cells (Pelus and Fukuda, 2006).
Here, we report that rapid neutrophil mobilization at 
the early stages of acute inflammation is mainly mediated by 
CXCR2 ligands. Although serum CXCR2 ligand concen-
trations increased during inflammation, neutrophil mobiliza-
tion slowed after an initial acute fast phase. This suggests that 
neutrophil responses to CXCR2 ligands are suppressed after 
the acute phase: we demonstrate that this is caused by the 
inhibition of CXCR2-mediated cellular signaling by G-CSF, 
which was expressed later in the acute inflammatory response. 
Although G-CSF is a well known neutrophil-mobilizing 
agent, inhibition of G-CSF activity in vivo unexpectedly 
elevated PB neutrophil counts in Escherichia coli–infected 
mice and, furthermore, sequestered neutrophils in the lungs 
to produce sterile pulmonary inflammation. Similarly, in an 
LPS-induced acute lung injury model, G-CSF blockade led 
to enhanced neutrophil accumulation in the lungs, edema, 
and severe lung inflammation. Thus, G-CSF not only acts as a 
neutrophil mobilizer, but also negatively regulates neutrophil 
mobilization by CXCR2 ligands: this is a previously unrec-
ognized neutrophil mobilization control mechanism during 
infection and inflammation. Furthermore, we demonstrate 
that the homeostatic imbalance caused by G-CSF suppression 
elicits neutrophil sequestration in the lungs and ultimately 
leads to significant lung damage.
RES ULTS
The instant PB neutrophilia induced by E. coli is 
mediated by CXCR2 ligands
To investigate the mechanism by which neutrophils are 
rapidly mobilized by chemokines and cytokines, we used a 
mouse peritonitis model of acute inflammation. Neutrophil 
numbers in the PB were elevated shortly after i.p. E. coli 
administration, with maximum blood levels reached at 90 
min (Fig. 1 A). The majority of the increase occurred in the 
first 30 min after induction of peritoneal infection, suggest-
ing that the regulatory cytokines must have similar dynamics 
(Fig.  1 B). Cytokine-specific ELI SAs showed that levels of 
the CXCR2 ligands MIP-2 (Fig. 1 C) and KC (Fig. 1 D) 
rapidly increased in blood serum, peaking at 30 min after E. 
coli injection. CXCR2 ligands appeared to be essential for 
neutrophil mobilization at this early phase of acute infection, 
as simultaneous injection of CXCR2-blocking antibodies 
suppressed E. coli–induced neutrophilia (Fig. 1 E). Treatment 
with CXCR2 ligand alone was also sufficient to induce PB 
neutrophilia. The effect of MIP-2 on neutrophil mobiliza-
tion was monitored by i.v. injection of MIP-2. 15 min after 
a single MIP-2 injection, there was a significant increase in 
circulating neutrophil numbers that was completely inhibited 
by CXCR2 antibodies (Fig. 1 F). Collectively, early neutro-
phil mobilization from the BM to the PB in response to acute 
infection appears to be caused, at least in part, by elevation of 
CXCR2 ligands in the blood.
G-CSF suppresses early-phase PB 
neutrophilia induced by E. coli
G-CSF is involved in the differentiation of myeloid progeni-
tor cells into neutrophils and is also routinely used to mobilize 
neutrophils from the BM in neutropenic patients. We exam-
ined the effect of G-CSF on E. coli–induced neutrophilia 
at different time points. Surprisingly, G-CSF did not further 
increase neutrophil numbers in the PB of E. coli–challenged 
mice; on the contrary, G-CSF dramatically suppressed infec-
tion-induced neutrophilia, particularly during early-phase 
(first 60 min) infection (Fig. 2 A). PB neutrophilia can also 
be affected by the rate of neutrophil recruitment to the site 
of inflammation. To assess the effect of G-CSF on neutrophil 
recruitment to tissues, neutrophils in peritoneal lavage fluid 
were counted after G-CSF and E. coli administration. G-CSF 
did not affect neutrophil recruitment to the inflamed peri-
toneal cavity, indicating that the G-CSF–induced reduction 
in PB neutrophilia was not caused by changes in neutrophil 
recruitment (Fig. 2 B).
G-CSF inhibits MIP-2–induced neutrophil 
mobilization from the BM
G-CSF mobilizes neutrophils by reducing CXCR4 expres-
sion on neutrophils and decreasing BM CXCL-12 expression 
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(Semerad et al., 2002, 2005). To further understand the mech-
anism by which G-CSF regulates blood neutrophilia during 
acute infection, we monitored the direct effect of G-CSF and 
MIP-2 alone and in combination on neutrophil mobiliza-
tion from the BM (Fig. 3 A). As early as 15 min after MIP-2 
injection, PB neutrophil numbers were drastically elevated 
compared with vehicle control (PBS), reaching a maximum 
at 30 min and returning to basal levels ∼2 h after injection. 
Conversely, G-CSF significantly reduced circulating neutro-
phil numbers and induced neutropenia 15 min after injection. 
This neutropenia was transient, as circulating neutrophil num-
bers increased after 15 min to reach normal levels by ∼30 min 
and continued to elevate thereafter (Fig. 3 A), in agreement 
with previous observations that circulating neutrophils de-
crease after a single G-CSF dose and then recover to normal 
levels (Gordon et al., 2007; DeJesus et al., 2011). Neutrophils 
appearing in the PB after MIP-2 stimulation originate from 
the BM; therefore, we counted BM neutrophils 60 min after 
MIP-2 or G-CSF injection. MIP-2–treated mice had reduced 
BM neutrophil counts compared with G-CSF–treated mice 
(Fig. 3 B), consistent with the less significant neutrophilia ob-
served in G-CSF–treated mice during early-stage infection. 
MIP-2 injection also increased circulating blood eosinophils 
(Fig. 3 C) but not monocytes or other cell types (Fig. 3 D).
Figure 1. Rapid neutrophil mobilization in early-stage acute inflammation is mainly mediated by CXCR2 ligands. (A) Neutrophil counts in PB after 
E. coli administration in the peritonitis model. Changes of PB neutrophil count over time were analyzed by one-way ANO VA–repeated measures. The control 
group was time 0. (B) The speed of neutrophil count changes at each indicated time period was quantified. The control group was −30 to 0 min. (C) The 
concentrations of CXCR2 ligand MIP-2 in blood serum. (D) The concentrations of CXCR2 ligand KC in blood serum. The control group was time 0 for each 
group. Differences over time between groups were analyzed using multivariate ANO VA with measures repeated over time. E.coli treatment significantly (P < 
0.01) increased serum MIP-2 and KC levels. (A–D) Dunnett's multiple comparison test versus the control group was used. (E) CXCR2 blockade suppresses 
rapid neutrophil mobilization during early-stage acute inflammation. CXCR2 antibodies or IgG (as control) was i.v. administered to each mouse. (F) CXCR2 
ligand MIP-2 induces rapid neutrophil mobilization. MIP-2 (1 µg in 100 µl PBS) and/or CXCR2 antibodies (2 µg in 100 µl PBS) were i.v. administered. 
(E and F) Student’s t test versus control (mice treated with IgG) was used. All data are means ± SD of three experiments (n = 6 mice). *, P < 0.01. Ab, antibody.
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To address whether G-CSF and MIP-2 synergistically 
mobilize neutrophils from the BM reservoir, mice were simul-
taneously injected with MIP-2 and G-CSF. This resulted in sig-
nificantly lower circulating neutrophil numbers compared with 
mice injected with MIP-2 alone (Fig. 3 A). At 15 min after 
administration of this cocktail, circulating neutrophil num-
bers were even lower than in vehicle-treated controls. Thus, 
G-CSF appears to play a negative role in infection-induced 
neutrophilia by inhibiting CXCR2 ligand–mediated neutro-
phil mobilization from the BM. MIP-2–induced eosinophilia 
was also inhibited by G-CSF (Fig. 3 C). The goal of this study 
is to demonstrate that G-CSF can inhibit MIP-2–elicited 
neutrophil mobilization from the BM. Thus, we used a 1 µg/
mouse dose of MIP-2 that could induce the maximal release 
of neutrophils from the BM with the least variation. This dose 
is similar to the optimal dose used by several other laboratories 
(McColl and Clark-Lewis, 1999; Liu et al., 2007; Wengner et 
al., 2008). It is higher than the endogenous MIP-2 levels elic-
ited by E.coli infection. This may be because of the low bioac-
tivity of recombinant MIP-2 protein.
The inhibitory effect of G-CSF on MIP-2–induced 
neutrophil mobilization seems to be specific. We explored 
whether other neutrophil-mobilizing agents had the same ef-
fect on MIP-2–induced neutrophil mobilization. AMD3100 
is a small molecule antagonist of CXCR4 that is known to 
induce rapid neutrophilia (Broxmeyer et al., 2005). In contrast 
to G-CSF, coadministration of MIP-2 and AMD3100 fur-
ther increased circulating neutrophil numbers compared with 
MIP-2 or AMD3100 alone (Fig. 3 E).
G-CSF decreases neutrophil mobility in the BM  
during  
MIP-2–induced neutrophil mobilization
To directly visualize neutrophil mobilization from the BM, 
multiphoton intravital microscopy (IVM [MP-IVM]) was 
used to monitor individual neutrophils in cranial BM. Mice 
expressing enhanced GFP (eGFP) under the control of the 
lysozyme M promoter (LysM-eGFP) were used to visualize 
eGFP-expressing neutrophil kinetics in the BM. This tech-
nique enables simultaneous visualization of the blood vessels 
and neutrophil behavior in the BM under homeostatic con-
ditions and during mobilization in response to an injected 
mobilizing agent. eGFP was only expressed in myeloid cells 
in LysM-eGFP mice, the vast majority being mature neutro-
phils, with eGFP expressed at much lower levels in other my-
eloid lineages such as macrophages and a subset of dendritic 
cells (Faust et al., 2000; Chtanova et al., 2008; Peters et al., 
2008). In addition, neither MIP-2 nor G-CSF had a signif-
icant effect on monocyte mobilization (Fig. 3 D); thus, the 
majority of migrating GFP+ cells detected here were neutro-
phils. Consistently, immunostaining of the BM slides showed 
that all GFP+ cells were positive for Ly6G, a specific marker 
for neutrophils (Fig. 4 A).
Treating mice with a single dose of recombinant 
mouse MIP-2 significantly increased neutrophil mobili-
zation and migration toward blood vessels within 15 min 
(Fig. 4, B–D and Videos 1 and 2). Neutrophil displacement, 
velocity, directionality, and upward directionality toward 
blood vessels increased rapidly after MIP-2 injection (Fig. 4, 
E–H). On average, ∼50% of neutrophils entered blood ves-
sels after MIP-2 injection in MIP-2–treated mice during 
the 60-min interval, with most entering the circulation 
15–25 min after injection (Fig. 4, I–J; and Videos 1 and 2). 
In this experiment, we tracked each single cell using MP-
IVM until it entered the vessels or until the end of the video 
(Fig.  4, C and D). The imaging depth of MP-IVM was 
100 µm. We started the recording at a z depth of ∼50 µm 
and recorded 50–60 µm in the z direction at 5 µm/section. 
Some cells would migrate in and out of the focal plane 
during the recording, but these cells could still be visu-
Figure 2. G-CSF inhibits rapid neutrophil mobilization from the BM 
during early-stage acute inflammation. (A) G-CSF inhibits E. coli–in-
duced rapid neutrophil mobilization. G-CSF (2 µg in 200 µl PBS) and E. coli 
(2 million in 1 ml PBS) were simultaneously injected i.p. into C57BL/6 mice. 
*, P < 0.01 by Student’s t test versus control (mice not treated with G-CSF 
at each time points). (B) G-CSF treatment does not affect neutrophil re-
cruitment to the inflamed peritoneal cavity. Neutrophil counts in the peri-
toneal lavage were measured at 30 and 60 min after E. coli administration. 
n = 10 mice for each group. All data are means ± SD of three experiments.
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alized under the microscope. We confirmed that the cells 
that were not seen by the end of the video were indeed 
those that entered circulation. These cells were not present 
even when we looked at each single optical sections (image 
stacks) of the three-dimensional projections, indicating that 
these cells most likely entered the circulation.
A very different effect was observed in mice treated 
with G-CSF. Although neutrophil displacement and veloc-
ity increased in G-CSF–treated mice (Fig.  4, E and F; and 
Video 3), there was no specific directionality (Fig. 4, G and 
H), and the cells did not enter circulation until 55–60 min 
after G-CSF injection (Fig.  4  I). Even then, only ∼20% of 
eGFP+ neutrophils entered the circulation (Fig. 4  J). Earlier 
experiments (Fig. 3 A) showed that G-CSF inhibited MIP-2–
induced mobilization in mice simultaneously injected with 
G-CSF and MIP-2, and a similar phenomenon was observed 
by IVM (Video 4). When mice were simultaneously injected 
with G-CSF and MIP-2, the neutrophils failed to reach veloc-
ities comparable with those in mice treated with MIP-2 alone 
(Fig. 4, E and F). As in G-CSF–treated mice, neutrophils in 
mice treated with G-CSF and MIP-2 lost directionality and 
entered the blood circulation much later than those in mice 
treated with MIP-2 alone (Fig. 4, G–J). Thus, the MP-IVM 
approach further demonstrates that G-CSF inhibited MIP-2–
induced mobilization of neutrophils from the BM.
G-CSF inhibits MIP-2–elicited neutrophil chemotaxis
In vivo experiments showed that MIP-2 failed to efficiently 
mobilize neutrophils when the mice were simultaneously 
treated with G-CSF, suggesting that G-CSF may negatively 
regulate MIP-2. MIP-2 is a neutrophil chemoattractant 
that plays a critical role in neutrophil recruitment in re-
sponse to infection and inflammation. Therefore, we inves-
tigated whether G-CSF impaired neutrophil chemotaxis in 
an MIP-2 gradient using the EZ-TAX IScan apparatus, in 
which a stable chemoattractant gradient is formed in a 260-
µm–wide channel, enabling direct visualization of neutrophil 
chemotactic migration. Mouse BM neutrophils were exposed 
to an MIP-2 gradient generated in the presence or absence 
of G-CSF, and cell movement was recorded by time-lapse 
microscopy and analyzed. Neutrophils migrated robustly in 
an MIP-2 gradient (Fig. 5, A–E; and Video 5). However, the 
presence of G-CSF in the chemotactic gradient severely re-
duced MIP-2–induced chemotaxis, with neutrophils show-
ing defective directionality and lower migration speed (Fig. 5, 
A–E; and Video 6). It is noteworthy that G-CSF was not in 
itself a chemoattractant and did not affect neutrophil mobility 
when applied alone (Fig. 5, A–E; and Video 7). In addition, 
the effect of G-CSF was unique to CXCR2-mediated neu-
trophil chemotaxis. G-CSF did not affect chemotaxis elic-
ited by other chemoattractants such as LTB4, C5a, or fMLP 
Figure 3. G-CSF specifically inhibits MIP-2–induced neutrophil mobilization from the BM. (A) MIP-2–induced neutrophil mobilization from the 
BM in the presence or absence of G-CSF. C57BL/6 mice were i.v. injected with the indicated cytokines. (B) Total numbers of neutrophils remaining in the 
BM 60 min after each treatment. AMD3100 is a small molecule antagonist of CXCR4. (C) MIP-2 induces eosinophil mobilization. (D) MIP-2 does not have a 
significant effect on monocyte mobilization from the BM. (E) CXCR4 antagonist AMD3100 further enhances MIP-2–induced neutrophil mobilization. Mice 
were i.v. injected with 1 µg MIP-2, 2.5 µg G-CSF, or 0.05 mg AMD3100 as indicated. All data shown are means ± SD of three experiments (n = 10 mice for 
each group). *, P < 0.01 by Student’s t test versus control (mice treated with PBS at each time point).
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(Fig. 5 F and Videos 8 and 9). Similar results were observed in 
both mouse and human neutrophils (Fig. 5 G). Collectively, 
these results demonstrate that G-CSF can specifically nega-
tively modulate MIP-2–mediated neutrophil chemotaxis.
G-CSF negatively regulates MIP-2–induced signaling
G-CSF treatment suppressed PB neutrophilia induced by E. 
coli but did not alter KC and MIP-2 levels, eliminating the 
possibility that G-CSF suppressed infection-associated neu-
trophilia by down-regulating CXCR2 ligand levels (Fig. 6 A). 
Consistent with this, in an in vitro assay, G-CSF directly in-
hibited MIP-2–elicited neutrophil chemotaxis. These results 
suggest that G-CSF regulates neutrophil function by modu-
lating MIP-2–induced intracellular signaling.
Neutrophils use various signaling cascades during che-
motaxis including PI3K/Akt and MAPK signaling. Neutro-
phil stimulation with MIP-2 induced robust phosphorylation 
of Erk1/2 and Akt. Interestingly, G-CSF dramatically reduced 
Figure 4. MIP-2–induced neutrophil mobilization from the BM is hindered in the presence of G-CSF. (A) GFP+ cells in LysM-eGFP mice are positive 
for Ly6G, a specific marker for neutrophils. Data shown are representative of four experiments with similar results. (B–J) Transgenic mice expressing eGFP 
under the control of the LysM promoter were i.v. injected with 1 µg MIP-2 or/and 2 µg G-CSF. The mobilization of GFP+ cells was monitored in vivo by 
MP-IVM (also see Videos 1, 2, 3, and 4). (B) Microscopy images at the indicated time points. Representative images from four independent experiments are 
shown. Arrows indicate neutrophils (time 0) that left upon the treatment. (C) Microscopy images illustrating the migratory patterns of neutrophils (GFP+ 
cells) in the parenchyma and sinusoids of calvarium BM in the first 25 (for MIP-2 alone) or 70 (for G-CSF and G-CSF + MIP-2) min after administration of the 
indicated cytokines. The tracks of several motile cells are shown. Tracks are sometimes partial because of the depth of the projected image. Bars: (A) 100 µm; 
(B and C) 50 µm. (D) Tracks of GFP+ neutrophils in the BM parenchyma, illustrating the different migrating patterns toward the blood vessels (y axis). GFP+ 
neutrophils were tracked after stimulant administration until they entered the vessels or until the end of the video (25 min for MIP-2 and 70 min for G-CSF 
and G-CSF + MIP-2). Tracks were obtained from IVM images and are illustrated as starting from a common starting point. (E) Displacement of parenchymal 
and sinusoidal GFP+ neutrophils in the first 25 (for MIP-2 alone) or 70 (for G-CSF and G-CSF + MIP-2) min after administration of the indicated cytokines. 
Total cell displacement was measured from the position at which each cell started at the beginning of the observation period to its location at the end of the 
recording. (F) Velocity of parenchymal and sinusoidal GFP+ neutrophils. (G) Directionality of neutrophils. (H) Upward directionality. (I) The mean time taken 
by GFP+ neutrophils to migrate from the parenchyma into the blood vessels after the indicated treatments. (J) Percentage of migrating GFP+ neutrophils 
that entered the circulation in the first 60 (for MIP-2 alone) or 70 (for G-CSF and G-CSF + MIP-2) min after administration of the indicated cytokines. Data 
shown are means ± SD of three experiments (n = 4–6 mice). *, P < 0.01 versus mice treated with MIP-2 alone.
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Figure 5. G-CSF inhibits MIP-2–induced neutrophil chemotaxis. (A) Chemotaxis of untreated or G-CSF–treated mouse neutrophils (also see Videos 
5, 6, and 7). (B) Tracks of migrating neutrophils (cells that moved at least 65 µm from the bottom of the channel; n = 10) were traced from the captured 
images, realigned such that all cells started from the same starting point (0,0), and plotted. Chemoattractant concentration increases in the positive y direc-
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MIP-2–elicited Erk1/2 phosphorylation but not Akt phos-
phorylation (Fig. 6, B and C). G-CSF signaling is mediated by 
phosphorylation and activation of STAT3 by the nonreceptor 
tyrosine kinase Janus kinase 2 (JAK2). G-CSF treatment rap-
idly increased STAT3 phosphorylation in neutrophils. To ex-
plore whether G-CSF–induced STAT3 activation is essential 
for suppression of MIP-2–elicited signaling, we investigated 
the effect of a JAK2 inhibitor, INCB018424, which com-
pletely inhibited STAT3 phosphorylation (Fig. 6, D and E). 
Blocking STAT3 phosphorylation with INCB018424 inhib-
ited the reduction in Erk1/2 phosphorylation in neutrophils 
stimulated with MIP-2 and G-CSF (Fig.  6 F) and also re-
versed G-CSF–induced neutrophil chemotaxis defects in the 
MIP-2 gradient (Fig. 6, G–K; and Videos 6 and 10). Collec-
tively, these results indicate that G-CSF–induced STAT3 sig-
naling negatively regulates MIP-2–elicited Erk1/2 signaling, 
which in turn regulates neutrophil chemotaxis.
Endogenously produced G-CSF negatively regulates rapid 
neutrophil mobilization at the early stage of acute infection
G-CSF is a hematopoietic cytokine generated by monocytes, 
macrophages, fibroblasts, and endothelial cells that is elevated 
by sepsis/severe bacterial infection in multiple clinical stud-
ies (Anderlini et al., 1996; Liu et al., 1996; Basu et al., 2002; 
Cottler-Fox et al., 2003; Gregory et al., 2007; Greenbaum and 
Link, 2011). However, based on our ELI SA results and previ-
ously published work (Metcalf et al., 1996), G-CSF increases 
later than KC or MIP-2 after E. coli–induced peritonitis. The 
levels of the CXCR2 ligands KC and MIP-2, but not G-CSF, 
rapidly increased in serum, peaking at 30 min after i.p. injec-
tion of E. coli (Fig. 1, B and C). In contrast, serum G-CSF 
levels began to increase 60 min after E. coli injection, peaking 
at 2 h (Fig. 7 A). To specifically investigate the function of en-
dogenously produced G-CSF in E. coli–induced peritonitis, 
mice were treated with a monoclonal anti–mouse G-CSF an-
tibody for 1 h before E. coli infection (Fig. 7 B). Circulating 
neutrophil counts were significantly elevated in mice treated 
with a G-CSF–blocking antibody. G-CSF antibody failed to 
augment neutrophil counts in mice treated with PBS alone, 
indicating that its effect was dependent on E. coli–elicited 
inflammation (Fig. 7 C). Neutrophil counts were also mea-
sured in the BM: mice treated with G-CSF–blocking anti-
bodies contained significantly less BM neutrophils both 2 and 
6 h after E. coli injection, confirming that the elevated PB 
counts were a result of augmented neutrophil mobilization 
from the BM (Fig. 7 D). Finally, more neutrophils were also 
observed in the peritoneum of G-CSF antibody–treated mice 
both 2 and 6 h after E. coli administration (Fig. 7 E), which 
may be the result of the peripheral neutrophilia observed in 
these mice. These results suggest that endogenously produced 
G-CSF during acute infection not only negatively regulates 
rapid neutrophil mobilization during early-stage infection, 
but also controls neutrophil recruitment to the site of inflam-
mation by modulating PB neutrophils.
Of note, treatment with G-CSF–blocking antibodies 
did not alter E. coli–induced elevation of MIP-2 and KC 
levels in the serum, confirming that G-CSF regulates neutro-
phil mobilization by modulating CXCR2-elicited signaling 
rather than altering CXCR2 ligand levels (Fig. 7 F).
Endogenous G-CSF prevents systemic 
neutrophil extravasation
Activation of PB neutrophils by chemokines and/or cyto-
kines is a prerequisite for neutrophil recruitment to infected 
tissues. However, uncontrolled neutrophil activation and/or 
elevated PB neutrophil counts may lead to systemic neu-
trophil extravasation and unwanted inflammation. Because 
endogenously produced G-CSF negatively regulates MIP-2–
elicited signaling and rapid neutrophil mobilization during 
early-stage acute infection, this may be an important mecha-
nism to prevent systemic neutrophil extravasation during in-
fection. To test this hypothesis, we suppressed G-CSF function 
using G-CSF–blocking antibodies and examined neutrophil 
accumulation in the lungs after injecting i.p. E. coli (Fig. 8 A).
Neutrophil accumulation in the lungs was assessed 6 h 
after bacterial injection using bronchoalveolar lavage (BAL; 
Fig. 8, B–D) and histological morphometric analysis of lung 
sections (Fig. 8, E–G). i.p. E. coli injection does not usually 
recruit neutrophils to the lungs, and as expected, very few 
neutrophils were detected in the lungs of unchallenged mice 
and mice challenged with i.p. injection of E. coli or i.v. in-
jection of IgG. However, when G-CSF–blocking antibodies 
were administered with E. coli, BAL neutrophils reached 
nearly 20% (Fig.  8  C) and levels of 3.5 × 105 (Fig.  8  D) 
6 h after bacterial injection. A similar accumulation was ob-
served in the lung tissue (Fig. 8 F) and in emigrated neutro-
phils in alveolar air spaces (Fig. 8 G) in histological sections 
quantified by morphometry.
Inflammation is associated with the release of cyto-
kines and chemokines at the site of infection, which sub-
sequently induce the accumulation and activation of 
neutrophils, monocytes/macrophages, and lymphocytes. 
Lung cytokine and chemokine levels increased in mice chal-
lenged by i.p. injection of E. coli and i.v. injection of G-CSF– 
blocking antibodies (Fig. 8 H). The proinflammatory cyto-
kines/chemokines IL-1α, IL-1β, IL-6, MIG/CXCL9 (mo-
nokine induced by γ interferon), and MCP-1 (monocyte 
chemoattractant protein 1) were increased in the BAL fluid 
(BALF) of anti–G-CSF antibody–treated mice. IL-1β was most 
elevated, showing approximately sevenfold-higher expression 
tion. (C–E) Tracks of migrating neutrophils were analyzed to determine directionality, upward directionality, and migration speed. (F) G-CSF does not affect 
chemotaxis elicited by LTB4, C5a, and fMLP in mouse neutrophils (also see Videos 8 and 9). (G) G-CSF specifically suppresses MIP-2–mediated chemotaxis of 
human neutrophils. Data are represented as means ± SD of three experiments (n = 20 cells). *, P < 0.01 versus neutrophils not treated with G-CSF.
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Figure 6. The inhibitory effect of G-CSF is mediated by activation of STAT3 signaling and the subsequent suppression of MIP-2–elicited cell 
signaling. (A) G-CSF treatment does not alter the KC and MIP-2 serum levels in mice i.p. injected with E. coli. Mice were i.p. injected with 2 ×106 CFU E. 
coli and/or i.v. injected with 2 µg G-CSF. Data shown are representative of three experiments (n = 5 mice). (B) Mouse BM neutrophils were stimulated with 
o
n
 February 8, 2017
D
ow
nloaded from
 
Published August 22, 2016
Negative regulation of CXCR2 signaling by G-CSF | Bajrami et al.2008
in G-CSF antibody–treated mice. The elevation of cytokine 
levels induced by G-CSF blockage was likely a result of the 
enhanced neutrophil recruitment because depletion of neu-
trophils with anti-Gr1 antibody abolished this G-CSF anti-
body–elicited effect (Fig. 8, I and J). However, the cytokine 
levels in the lungs remained high even in neutrophil-depleted 
mice, indicating that neutrophils were not the direct source of 
cytokine production. Collectively, these results indicate that 
G-CSF blockade in mice challenged with i.p. E. coli leads to 
neutrophil accumulation and inflammation in the lungs.
Blocking G-CSF aggravates LPS-induced lung injury
Exaggerated neutrophil accumulation can lead to tissue dam-
age. Endogenously produced G-CSF negatively regulates 
CXCR2-mediated rapid neutrophil mobilization and activa-
tion during infection. Thus, blocking G-CSF may enhance 
neutrophil recruitment at the site of infection by increasing 
PB neutrophils and augmenting their activation. We tested 
this hypothesis in an LPS-induced acute lung inflammation 
model (Fig. 9 A). Neutrophil accumulation and edema for-
mation in inflamed lungs was assessed 6 h after intratracheal 
LPS instillation by BAL and morphometric analysis of lung 
sections. As expected, very few neutrophils were observed in 
untreated mice. Instillation of LPS induced significant neu-
trophil accumulation in the lungs. Treatment with G-CSF–
blocking antibodies further elevated neutrophil accumulation 
(Fig.  9, B–D). Approximately twice as many neutrophils 
were present in the alveolar air spaces of mice treated with 
G-CSF antibodies (Fig. 9 C). The number of neutrophils in 
the BALF of G-CSF antibody–treated mice was also higher 
after LPS instillation compared with IgG antibody–treated 
control mice (Fig. 9 D).
Increased numbers of neutrophils in the lungs can lead 
to tissue damage and edema (Doerschuk, 2000). Edema was 
formed in mouse lungs after LPS treatment. Consistent with 
elevated neutrophil recruitment, greater edema formation 
was noted in the lungs of mice treated with G-CSF antibod-
ies (Fig. 9 E). Lung damage is often accompanied by vascular 
leakage, and increased BAL protein levels are used as an in-
dicator of vascular leakage and a surrogate of inflammatory 
lung injury. We consistently detected augmented pulmonary 
protein accumulation in the lungs of G-CSF antibody–treated 
mice (Fig. 9 F), again confirming that G-CSF–blocking anti-
body treatment exaggerates LPS-induced lung inflammation. 
Increasing the dose of instilled LPS from 0.5 to 2 mg/kg fur-
ther induced neutrophil recruitment, edema formation, and 
vascular leakage in both G-CSF antibody–treated and iso-
type control-treated mice (Fig. 9, C–E). The effect of G-CSF 
antibodies was observed under all experimental conditions 
used in the current study.
Collectively, these results indicate that endogenously 
produced G-CSF plays a critical role in negatively regulat-
ing neutrophil recruitment in acute lung inflammation, thus 
preventing exaggerated neutrophil accumulation and inflam-
mation-induced lung damage. Disrupting G-CSF signaling 
enhances neutrophil accumulation in the lungs, edema for-
mation, and severe lung inflammation in LPS-treated mice.
DIS CUS SION
Neutrophil homeostasis is maintained, in part, by their regu-
lated release from the BM. The chemokine CXCL12 (stromal 
cell–derived factor 1), by interacting with its major receptor 
CXCR4, plays a critical role in controlling neutrophil mobi-
lization and homeostasis under both basal and stress granulo-
poiesis conditions (Martin et al., 2003; Suratt et al., 2004; Eash 
et al., 2009, 2010; Petty et al., 2009). In addition to CXCR4, 
CXCL2/CXCR2 signaling is considered to be a second 
chemokine axis required for neutrophil mobilization (Eash et 
al., 2010). CXCR2 ligands stimulate neutrophil mobilization 
in a VAL4-dependent manner (Burdon et al., 2005). Based 
on a proposed tug-of-war model, CXCL2/CXCR2 signals 
and CXCL12/CXCR4 signals act antagonistically to regulate 
neutrophil retention in and release from the BM (Eash et al., 
2010). In the current study, we show that CXCR2 ligands 
MIP-2 and KC were quickly expressed during acute inflam-
mation and were responsible for initial rapid neutrophil mobi-
lization. The concentrations of CXCR2 ligands continued to 
increase during inflammation; however, the speed of neutro-
phil mobilization slowed after the initial acute fast phase. We 
demonstrate that this slowing of neutrophil release is caused 
by suppression of CXCR2-mediated signaling by G-CSF.
G-CSF is a prototypical neutrophil-mobilizing cy-
tokine. G-CSF–induced down-regulation of CXCR4 ex-
pression is one mechanism for mobilization of myeloid cells 
(Nagase et al., 2002; Kim et al., 2006). Humans and mice 
treated with AMD3100, a selective CXCR4 antagonist, or 
CXCR4-blocking antibodies undergo rapid PB neutrophilia 
(Broxmeyer, 2008; Eash et al., 2009). The CXCR4 antago-
MIP-2, G-CSF, or G-CSF + MIP-2 for the indicated times. Phosphorylated STAT3 (P-STAT3), ERK1/2 (P-ERK1/2), and AKT (P-AKT) levels were analyzed by West-
ern blotting. Data shown are representative of four independent experiments. (C) Relative amounts of phosphorylated Akt, Erk, and STAT3 were quantified 
with ImageJ software (National Institutes of Health; Subramanian et al., 2007). All samples were normalized to total actin. Basal level refers to phosphory-
lated protein levels at time 0 min. Data are representative of four independent experiments. Student’s t test was used. (D) The inhibitory effort of G-CSF– on 
MIP-2–elicited signaling was rescued by 0.5 µg/ml JAK inhibitor INCB018424. (E) JAK inhibitor INCB018424 blocks G-CSF–elicited STAT3 phosphorylation. 
(F) Treatment with INCB018424 reverses G-CSF–induced reduction of Erk phosphorylation in cells stimulated with MIP-2. Data are representative of four 
independent experiments. (G–K) The inhibitory effect of G-CSF on MIP-2–elicited neutrophil chemotaxis could be rescued by JAK inhibitor INCB018424. 
(G) Chemotaxis of mouse neutrophils in response to MIP-2 (also see Videos 6 and 10). (H) Tracks of migrating neutrophils. (I–K) Neutrophil chemotaxis was 
analyzed for migration speed (I), directionality (J), and upward directionality (K) as described in Fig. 5 (C–E). Data are representative of three experiments 
(n = 20 cells). All data are represented as means ± SD. *, P < 0.01 versus neutrophils treated with G-CSF but not INCB018424.
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nist plerixafor can also correct leukopenia in patients with 
warts, hypogammaglobulinemia, infections, and WHIM 
(warts, hypogammaglobulinemia, immunodeficiency, and 
myelokathexis) syndrome (Dale et al., 2011; McDermott et 
al., 2011, 2014). It is noteworthy that a recent study indicated 
that plerixafor-mediated CXCR4 inhibition does not mobi-
lize neutrophils from the BM. Instead, it elicits neutrophilia 
by promoting neutrophil release from the marginated pool 
present in the lung and preventing neutrophil circulation 
back to the BM (Devi et al., 2013). This demargination is 
likely to be caused by increased neutrophil blood velocities 
and decreased endothelium–neutrophil interactions (Doer-
schuk et al., 1988). A recent study also suggested that auto-
phagy plays a role in G-CSF–elicited stem cell mobilization 
(Leveque-El Mouttie et al., 2015).
Here, we found that G-CSF was expressed after MIP-2 
and KCs were expressed during acute infection. MIP-2– 
induced neutrophil mobilization from the BM was hindered by 
G-CSF, which negatively regulated MIP-2–induced signaling 
and inhibited MIP-2–elicited neutrophil chemotaxis. Impor-
tantly, the effect of G-CSF was unique to CXCR2-mediated 
chemotaxis. G-CSF did not affect chemotaxis elicited by other 
chemoattractants such as LTB4, C5a, or fMLP. Thus, G-CSF 
mainly regulates neutrophil trafficking at the early stage of in-
fection. It would not suppress neutrophil chemotactic migra-
tion toward pathogens, a process mainly mediated by fMLP and 
C5a. It is well documented that neutrophil chemotaxis can be 
driven by diverse chemotactic signaling pathways depending on 
the chemoattractant gradient being exposed to the cells (Fox-
man et al., 1997; Heit et al., 2002, 2008). The molecular basis 
underlying the specificity of G-CSF toward CXCR2 ligands is 
still largely unknown and needs to be further investigated.
Strikingly, despite its well known neutrophil-mobilizing 
function, endogenously produced G-CSF negatively regu-
lated rapid neutrophil mobilization during early-stage acute 
infection. Blocking G-CSF in vivo unexpectedly elevated PB 
neutrophil counts in mice injected i.p. with E.coli and re-
sulted in sequestration of large numbers of neutrophils in the 
lungs and sterile pulmonary inflammation. Finally, we found 
that endogenously produced G-CSF also played a critical role 
by negatively regulating neutrophil recruitment in an LPS-in-
duced acute lung inflammation model, thus preventing exag-
gerated neutrophil accumulation and inflammation-induced 
lung damage. Blocking G-CSF led to enhanced neutrophil 
accumulation in the lungs, edema formation, and more se-
vere lung inflammation in LPS-treated mice. This represents 
a previously undefined mechanism by which G-CSF controls 
neutrophil mobilization and homeostasis during infection and 
inflammation. Because both G-CSF and CXCR2 ligands are 
capable of mobilizing hematopoietic stem/progenitor cells, 
the mechanism identified here may also play a role in regulat-
ing hematopoietic grafts and hematopoiesis.
Figure 7. Blocking G-CSF increases rapid neutrophil mobilization during early-stage acute inflammation. (A) The G-CSF concentration in blood 
serum after administration of E. coli. 106 CFU E. coli or PBS (as control) was i.p. injected. (B) Mice were treated with 100 µg G-CSF antibody for 1 h before 
administration of E. coli. IgG was administered to the control group. (C) PB neutrophil counts were measured using a HemaVet 850 hematology system. 
Fold increases compared with mice treated with E. coli only (or PBS only as a control) at each time point are shown. (D) Total number of neutrophils in the 
BM. (E) The number of neutrophils in peritoneal lavage was measured by flow cytometry analysis 2 and 6 h after E. coli administration. (F) Blocking G-CSF 
activity does not alter KC and MIP-2 levels in mice i.p. injected with E. coli. n = 4–6 mice. Data shown are means ± SD of three experiments. *, P < 0.01 
versus mice treated with IgG.
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Interactions between G-CSF and CXCR2 ligand have 
been previously investigated. It is proposed that G-CSF– 
induced neutrophil mobilization is mediated by CXCR2 
ligands (Eash et al., 2010; Köhler et al., 2011). CXCR2 li-
gand expression in megakaryocytes and endothelial cells is 
up-regulated after G-CSF treatment. In CXCR2-deficient 
Figure 8. Blocking G-CSF activity induces neutrophil sequestration in the lungs, leading to sterile pulmonary inflammation in mice i.p. in-
jected with E. coli. (A) Schematic representation of the experimental procedures. (B) Cells in BALF were stained with a modified Wright–Giemsa stain (40× 
immersion oil). (C) The percentage of neutrophils in BALF. (D) Neutrophil counts in BALF. (E) Staining of lung sections shows emigrated neutrophils in the 
lungs (20× dry lens). (F) The number of cells in the lung capillaries was quantified as the number of cells in total capillaries (but not alveolar air spaces)/10 
alveolar air space area using ImageJ. (G) Emigrated neutrophils in alveolar spaces were quantified as volume fraction of the alveolar air space using standard 
point-counting morphometric techniques. (H) Cytokine/chemokine levels in BALF were measured using specific ELI SA kits. (I and J) G-CSF blockage–induced 
elevation of cytokine levels in the lungs is mediated by neutrophils. (I) Schematic representation of the experimental procedures. Neutrophils were depleted 
by a Gr-1 antibody in both PB (∼85% depletion) and the BM (∼65% depletion; Kwak et al., 2015). (J) Cytokine/chemokine levels in BALF. Data shown are 
means ± SD of three experiments (n = 5 mice). *, P < 0.01 versus control (mice treated with IgG).
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mice, G-CSF fails to induce neutrophil mobilization (Eash 
et al., 2010; Köhler et al., 2011). In contrast, expression of 
G-CSF can also be regulated by CXCR2. CXCR2 acti-
vation on neutrophils by the CXCR2 ligand CXCL5 de-
rived from gut-resident cells negatively regulates IL-17A and 
G-CSF expression. In the absence of this CXCR2-dependent 
negative feedback, commensal bacteria can promote IL-17A 
and G-CSF expression (Mei et al., 2012). Previous studies 
indicate that G-CSF and CXCR2 ligands synergistically 
regulate hematopoietic cell mobilization. A single dose of 
the CXCR2 ligand MIP-2 synergistically enhances hema-
topoietic stem and progenitor cell mobilization when used 
in combination with G-CSF, and this effect is dependent on 
neutrophil-derived MMP-9 (Pelus et al., 2004). However, a 
later study showed that hematopoietic progenitor cell mo-
bilization by G-CSF was normal in MMP9-deficient mice, 
suggesting protease-independent pathways may also contrib-
ute to hematopoietic progenitor cell mobilization (Heissig et 
al., 2002; Levesque et al., 2004). Using an in situ perfusion 
system of mouse femoral BM, Wengner et al. (2008) reported 
that the CXCR2-selective chemokine KC and G-CSF mo-
bilized significantly more neutrophils when applied together, 
indicating that these factors act cooperatively to regulate 
neutrophil mobilization. However, the result was not con-
firmed in animal models. Paradoxically, here, we observed 
suppression of MIP-2–induced neutrophil mobilization by 
G-CSF at early time points (Fig. 3) and clear enhancement 
of infection-induced neutrophil mobilization in mice treated 
with G-CSF–blocking antibody (Fig. 7). We reason that the 
synergistic effect of G-CSF and CXCR2 ligands only occurs 
after the acute early phase.
G-CSF is a well known hematopoietic cytokine and 
a major regulator of neutrophil homeostasis (Anderlini et 
al., 1996; Liu et al., 1996; Basu et al., 2002; Cottler-Fox et 
al., 2003; Gregory et al., 2007; Greenbaum and Link, 2011). 
G-CSF is used clinically to restore neutrophil numbers in 
neutropenia-related pneumonia patients by stimulating the 
BM to produce more neutrophils. G-CSF also plays a crit-
ical role in homeostatic regulation of neutrophil production 
by efferocytosis (clearance of apoptotic neutrophils; Bratton 
and Henson, 2011; Poon et al., 2014). Neutrophil produc-
tion needs to match neutrophil elimination to maintain ap-
proximately constant circulating numbers. Efferocytosis of 
apoptotic neutrophils in tissues by macrophages and dendritic 
cells leads to reduced phagocyte secretion of IL-23, a cyto-
kine controlling IL-17 production by γ-δ T cells and uncon-
ventional α-β T cells. IL-17, in turn, regulates granulopoiesis 
through G-CSF (Stark et al., 2005; Smith et al., 2007). The 
current dogma proposes that G-CSF is an important proin-
flammatory cytokine (Eyles et al., 2008; Cornish et al., 2009; 
Vlahos et al., 2010). Our result that G-CSF negatively regu-
lates neutrophil mobilization is somewhat surprising. A sim-
ilar effect was also observed in an E. coli pneumonia model 
in which G-CSF treatment paradoxically decreased circu-
Figure 9. Blocking G-CSF activity aggravates LPS-induced acute lung inflammation. (A) Schematic representation of the experimental procedures. 
(B) Staining of lung sections shows emigrated neutrophils and polymerized fibrin in the pulmonary parenchyma. (C) The number of neutrophils emigrating 
to alveolar air spaces was quantified as volume fraction of the alveolar air space using standard point-counting morphometric techniques. (D) Neutrophil 
counts in BALF were calculated using the Wright–Giemsa staining method. (E) Pulmonary edema formation. (F) BALF total protein. The standard curve was 
constructed using BSA. Data shown are means ± SD of four experiments (n = 6 mice). *, P < 0.01 versus control (mice treated with IgG).
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lating neutrophil counts, resulting in reduced host defense, 
impaired bacterial killing, and thus aggravated pulmonary 
injury (Karzai et al., 1999). We demonstrated that G-CSF 
does not synergize with CXCR2 chemokines to induce 
neutrophil mobilization during early-phase infection. Instead, 
it inhibits CXCR2-mediated rapid neutrophil mobilization. 
In multiple clinical studies, G-CSF is elevated upon sepsis/
severe bacterial infection. However, it is produced relatively 
late compared with KC and MIP-2 in mice. This ensures that 
the initial CXCR2-mediated neutrophil mobilization can 
occur at maximal levels without G-CSF–induced inhibition. 
Rapid release of neutrophils into the circulation then leads 
to maximal neutrophil recruitment to the site of infection 
and, in doing so, maximizes the bactericidal capability of the 
host. At later stages of infection, G-CSF is produced to sup-
press CXCR2-mediated rapid neutrophil mobilization and 
to initiate more controlled regulation characterized by accel-
erated granulopoiesis and G-CSF–mediated slow neutrophil 
mobilization from the BM.
Although G-CSF has been routinely used to treat neu-
tropenia, transient neutropenia often occurs shortly after 
G-CSF administration. A recent study suggests that this tran-
sient neutropenia is mainly caused by neutrophil accumu-
lation in pulmonary vasculature (DeJesus et al., 2011) and 
might be mediated by leukocyte integrin activation after 
G-CSF administration (Donahue et al., 2011). Our results 
indicate that G-CSF–induced inhibition of CXCR2 signal-
ing may be an alternative mechanism leading to G-CSF–elic-
ited transient neutropenia.
Absolute neutrophil counts in the PB reflect the body’s 
neutrophil supply under normal steady-state conditions. 
However, when neutrophils are produced under stress con-
ditions such as drug treatment, infection, chemotherapy, or 
hematopoietic transplantation, neutrophil tissue repopulation 
and functional capacity becomes a more reliable proxy for 
neutrophil supply and restoration of innate immune protec-
tion (Cheretakis et al., 2006; Devi et al., 2013). CXCR2-me-
diated cell signaling is important for not only neutrophil 
mobilization from the BM, but also for various neutrophil 
functions such as polarization, reactive oxygen species pro-
duction, chemotaxis, and survival. It controls neutrophil traf-
ficking, accumulation, and function in host defense. Thus, 
G-CSF negatively regulating CXCR2 signaling indicates a 
novel mechanism by which neutrophil recruitment and func-
tion are regulated by G-CSF in innate immunity.
In summary, our results provide evidence that, although 
commonly used to increase granulocyte production in the BM 
and to promote their mobilization, G-CSF has a negative ef-
fect on CXCR2-mediated neutrophil mobilization from the 
BM at a very early phase of acute inflammation. By negatively 
regulating CXCR2-elicited signaling, G-CSF also suppresses 
neutrophil activation and function. This study reveals a novel 
cellular mechanism for regulating neutrophil homeostasis and 
function during acute infection and inflammation. Neutrophils 
are involved in numerous pathological conditions, many of 
which result from homeostatic imbalance. Our findings may 
lead to new therapeutic strategies for the treatment of a variety 
of hematological, infectious, and inflammatory diseases.
MAT ERI ALS AND MET HODS
Mice
C57BL/6J mice were purchased from Charles River or The 
Jackson Laboratory. Mice expressing eGFP (eGFP loxP/loxP) 
and myeloid-specific Cre (LysM-Cre) mice were purchased 
from The Jackson Laboratory. eGFP gene expression was 
achieved by breeding eGFP mice with myeloid-specific Cre 
mice. All mice were housed in pathogen-free conditions at 
the Children's Hospital Animal Facility. 8–12-wk-old mice 
were used in all experiments. All procedures involving mice 
were monitored and approved by the Children’s Hospital An-
imal Care and Use Committee.
Mouse peritonitis model
106 CFU E. coli (strain 19138; American Type Culture Col-
lection) in 1 ml PBS was i.p. injected in C57BL/6J mice. At 
the indicated time after E. coli administration, the mice were 
euthanized by CO2 inhalation. PB was collected by retroor-
bital bleeding at each time point. Neutrophil counts in the 
PB and BM after E. coli administration were measured using 
a hematology system (HemaVet 850; Erba Diagnostics, Inc.). 
Cells in the peritoneum were recovered by flushing the peri-
toneum cavity with 5 ml of ice-cold PBS containing 5 mM 
EDTA and collecting the peritoneal lavage. The process was 
repeated three times. To check the neutrophil content in the 
lungs after peritonitis, mice were euthanized by CO2 at the 
indicated time after E. coli administration. The chest cavity 
was opened, and a catheter was tied to the trachea. The BAL 
(1  ml PBS/15  mM EDTA, 10×) was collected from each 
mouse in each group. The BALF was centrifuged at 450 g for 
10 min, and the total and differential cell counts were deter-
mined from the pelleted cell fraction. The total cell counts 
were determined using a hemocytometer, and the differen-
tial cell counts were conducted by microscopic analysis of 
Wright–Giemsa-stained cytospin or with a flow cytometer 
(FAC SCanto II) and FAC SDiva software (BD). The absolute 
number of neutrophils was then determined based on the cy-
tospin or FACS analysis. For microscopic analysis, neutrophils 
were recognized by their lobular or segmented nuclei. The 
percentage of polymorphonuclear neutrophils (PMNs) in the 
whole population (%PMN) was determined accordingly. The 
total number of neutrophils (#PMN) recruited was calculated 
as follows: #PMN = cell density × volume × %PMN. For 
flow cytometry analysis (Fig. S1), cells were passed through a 
strainer and stained with Gr1-APC (BioLegend) and CD11b-
FITC (BioLegend) antibodies. Unstained cells were used as a 
negative control to establish the flow cytometer voltage setting, 
and single-color positive controls were used for adjustment 
of the compensation. Samples were run on a flow cytome-
ter (FAC SCanto II; BD) and analyzed using FlowJo software 
(Tree Star). Neutrophils were defined as Gr1+CD11b+ cells.
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Mice were anesthetized with 100 mg/kg ketamine 
hydrochloride and 10 mg/kg xylazine i.p. The frontoparietal 
skull bone was exposed and prepared for IVM following 
previously established protocols (Mazo et al., 1998). Two-
photon microscopy on the calvarium BM was performed using 
a fluorescence microscope (BX50WI; Olympus) equipped 
with a 20×, 0.95 numerical aperture objective (Olympus) and 
a multiphoton microscopy system (Radiance 2000MP; Bio-
Rad Laboratories) controlled by Lasersharp software (Bio-
Rad Laboratories). For two-photon excitation and second 
harmonic generation, a MaiTai Ti :Sapphire laser was tuned 
to a range of wavelengths from 800 to 875 nm. Mice were 
cannulated before imaging. Blood vessels were labeled with 
tetramethylrhodamine-dextran (2,000,000 MW; Invitrogen; 
Thermo Fisher Scientific). Neutrophils were detected by 
eGFP fluorescence, and bone was visualized by its second 
harmonic generation signal. Images were recorded every 
30–40 s for 70 min after injection of MIP-2, G-CSF, indicated 
antibodies, or PBS. The generated image stack sequences were 
transformed into volume-rendered four-dimensional videos 
using Volocity software (PerkinElmer), which was also used 
for tracking cell motility in three dimensions. Directionality 
(0 to 1) was calculated as the straight-line migration distance 
from the origin divided by the total migration length. Upward 
directionality (−1 to 1) was calculated as the straight-line 
distance migrated in the direction toward the blood vessel 
divided by total migration length.
Immunofluorescent staining
LyzM-eGFP mice were perfused postmortem with 10  ml 
paraformaldehyde-lysine-periodate fixative through the 
vena cava to achieve rapid in situ fixation and optimal pres-
ervation of the BM tissue. Femoral bones were isolated, 
fixed in paraformaldehyde-lysine-periodate for 4–8  h, re-
hydrated in 30% sucrose/PBS for 48  h, and snap frozen 
in optimal cutting temperature compound (TissueTek). 
Cryosections of nondecalcified whole longitudinal femo-
ral bones were obtained using a cryostat (CM3050S; Leica 
Biosystems) and the Cryojane tape transfer system (Leica 
Biosystems). After blocking with normal serum, the slides 
were incubated with primary antibody (rabbit anti-Ly6G 
from Abcam) for 30 min at room temperature. Next, the 
slides were washed three times with PBS followed by in-
cubation with Texas red–conjugated goat anti–rabbit IgG 
secondary antibody (Thermo Fisher Scientific). DAPI 
(Invitrogen) staining was used for nuclear detection, and 
sections were mounted with Vectashield mounting me-
dium for immunofluorescence (Vector Laboratories). High- 
resolution images of whole longitudinal immunostained 
femoral sections were obtained with an iCys Research Im-
aging cytometer (Compucyte Corporation) equipped with 
four laser lines (405, 488, 561, and 633 nm) and four pho-
tomultiplier tube detectors with bandpass emission filters at 
450/40, 521/15, 575/50, and 650LP.
Cytokine/chemokine stimulation
1 µg MIP-2 in 100  µl PBS, 2 µg of human recombinant 
G-CSF (Neupogen; Amgen) in 100 µl of PBS, or a cock-
tail of both (1 µg MIP-2 and 2 µg G-CSF in 100  µl of 
PBS) were i.v. injected into mice. Control animals were 
i.v. injected with an equivalent volume of endotoxin-free 
PBS. Circulating neutrophil numbers were determined by 
collecting 50  µl PB by retroorbital puncture at the indi-
cated time points. Blood content analysis was performed 
using the hematology system (HemaVet 850). The same 
amount of MIP-2 or G-CSF was i.v. injected into animals 
for intravital imaging.
Neutrophil isolation
Mouse BM-derived neutrophils were isolated using nega-
tive depletion of other cell populations using a neutrophil 
isolation kit (MidiMACS) following a protocol provided by 
the manufacturer (Miltenyi Biotec). The isolation procedure 
was conducted at 4°C unless specified. In brief, BM cells 
were filtered through a 70-µm cell strainer and suspended in 
250 µl PBS containing 0.5% endotoxin-free BSA and 2 mM 
EDTA (magnetic-activated cell-sorting [MACS] buffer). Cells 
were incubated with anti–mouse Ter119, B220, CD5, CD117, 
CD49b, F4/80, CD4, and CD11c antibodies for 5 min, washed 
once with 1.5 ml of cold MACS buffer, and then incubated 
with goat anti–rat IgG microbeads for 5–10 min, washed 
with 1.5 ml MACS buffer, and suspended in 250 µl MACS 
buffer. Cells were subsequently loaded onto a MACS buf-
fer–equilibrated LD column (Miltenyi Biotec) and washed 
twice with 1 ml MACS buffer. The flow through was har-
vested, washed twice with 10 ml of ice-cold RPMI medium 
containing 10% FBS/1% penicillin/streptomycin and allowed 
to warm up to room temperature in 10 ml RPMI medium 
until used. Human neutrophils were isolated from discarded 
white blood cell filters (WBF2 filter; Pall Corporation) as 
previously described (Zhu et al., 2006). In brief, erythrocytes 
were sedimented by adding an equal volume of dextran/saline 
solution (3% dextran T-500 in 0.9% NaCl) at room tempera-
ture for 25 min. The erythrocyte-depleted supernatants were 
then layered on lymphocyte separation medium (1.077 g/ml 
Ficoll-Hypaque solution; Voigt Global Distribution LLC) and 
centrifuged at 400 g at room temperature for 20 min. Con-
taminated erythrocytes in the neutrophil pellets were lysed 
after a brief (<30 s) treatment with 0.2% NaCl. Neutrophils 
were then resuspended in RPMI 1640 medium containing 
10% heat-inactivated FBS at a density of 4 × 106 cells/ml and 
maintained at 37°C. The purity of neutrophils was >97% as 
determined by Wright–Giemsa staining. All blood was drawn 
from healthy blood donors. All protocols have been approved 
by the Children’s Hospital Institutional Review Board and 
are subjected to annual review.
Measurement of cell signaling in mouse neutrophils
Mouse BM neutrophils were isolated by negative selection 
as described in the previous paragraph. Isolated BM neutro-
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phils were resuspended in HBSS/0.1% BSA and treated with 
0.1 µg/ml MIP-2, 0.1 µg/ml G-CSF, 0.5 µg/ml MIP-2 + 
G-CSF, or 0.5 µg/ml MIP-2 + G-CSF + INCB01842 for 
the times indicated. Cell lysates were analyzed for phosphor-
ylated STAT3, ERK1/2, and AKT using specific antibodies 
(Cell Signaling Technology) by Western blotting. Actin was 
used as a loading control.
LPS-induced acute lung inflammation
Mice were anesthetized with 100 mg/kg ketamine hy-
drochloride i.p. and 10 mg/kg xylazine i.p. After anesthe-
sia, mouse tracheas were surgically exposed (Li et al., 2009, 
2011), and a total volume of 50 µl LPS (from E. coli o55:B5; 
Sigma-Aldrich) per mouse was instilled intratracheally via an 
angiocatheter that was inserted through the trachea and into 
the left bronchus. To indicate correct deposition, 1% colloidal 
carbon was included in the instillate. Upon completion of the 
experiment, mice were euthanized by CO2.
Effect of G-CSF on neutrophil count in peritonitis model
Mice were i.v. injected with either monoclonal anti–mouse 
G-CSF antibody (100 µg in 100 µl PBS; R&D Systems) or 
human recombinant G-CSF (2 µg in 100 µl PBS; Neupogen; 
Amgen) 1 h before the peritoneal E. coli infection. Control 
antibody (rat anti–mouse IgG1 antibody) or PBS was used 
in control experiments. Peritoneum lavage and BALF con-
tent were then analyzed.
EZ-TAX IScan chemotaxis assay
The EZ-TAX IScan chamber (Effector Cell Institute) was as-
sembled with a 260-µm–wide × 4-µm–thick silicon chip on 
a 2-mm untreated glass base as described by the manufacturer 
and filled with RPMI medium/0.1% BSA. 1 µl of freshly pu-
rified WT mouse neutrophils (3 × 106/ml) were added to the 
lower reservoir of each of the six channels and allowed to line 
up by removing 18 µl of buffer from the upper reservoir. RPMI 
medium/0.1%BSA was then added to fill both reservoirs to 
the brim. 1 µl MIP-2 (500 ng/ml), G-CSF (500 ng/ml), fMLP 
(1 µM for mouse neutrophils and 100 nM for human neutro-
phils), IL-8 (100 nM), LTB4 (100 nM), or C5a (100 nM) was 
then added to the upper reservoir, and neutrophil migration (at 
37°C) in each of the channels was captured sequentially every 
30 s for 20 min using a 10× lens. To determine the involvement 
of G-CSF signaling in chemotaxis, neutrophils were exposed 
to 1 µg/ml G-CSF or 0.5 µg/ml JAK inhibitor INCB018424.
Analysis of cell tracks and morphology
(x,y) coordinates of migrating neutrophils (i.e., neutrophils 
that cross >65 µm from the starting line) were tracked from 
sequential images using Dynamic Image Analysis System soft-
ware (Solltech). Cell tracks were then realigned such that all 
the cells started from the same starting point (0,0) and were 
plotted using Matlab (MathWorks). Chemoattractant con-
centration increases in the positive y direction. Directionality 
(0 to 1) is defined as straight-line migration distance from the 
origin divided by the total migration length. Upward direc-
tionality (−1 to 1) is defined as straight-line distance migrated 
in the upward direction divided by total migration length and 
migration speed. Migration speed (µm/min) was calculated 
as the mean of cell speeds (migration distance between the 
current frame and the previous frame divided by the time 
between sequential frames; 0.5 min) at each captured frame.
Neutrophil recruitment in the inflamed lungs
Mice were anesthetized and instilled with 50 µl LPS (from 
E. coli o55:B5; Sigma-Aldrich). At the indicated time points, 
mice were euthanized by CO2. The chest cavity was opened, 
and a catheter was tied to the trachea. BAL was performed 
(1 ml PBS/15 mM EDTA 10×) in each group. The BALF was 
centrifuged at 450 g for 10 min, and the total and differential 
cell counts were determined from the pelleted cell fraction. 
The total number of cells in the lungs was counted by a hemo-
cytometer. Differential cell counts were conducted on cyto-
spin preparations stained with a modified Wright–Giemsa stain 
(Volu-Sol, Inc.). Neutrophils were recognized by their lobular 
or segmented nuclei. The percentage of pulmonary PMNs in 
the whole population (%PMN) was determined accordingly. 
Total number of pulmonary PMNs (#PMN) recruited was cal-
culated as follows: #PMN = cell density × volume × %PMN.
BALF cytokine and chemokine levels and total protein levels
BALF samples were obtained from mice at the indicated time 
points. BAL was done with 1 ml of cold PBS/15 mM EDTA, 
flushed back and forth three times. The levels of MIP-2 and 
KC in the BALF were measured with ELI SA kits following a 
protocol provided by the manufacturer (R&D Systems). Addi-
tionally a mouse 32-plex cytokine/chemokine panel was per-
formed by Eve Technologies to evaluate the levels of cytokines 
and chemokines present in the lungs after intratracheal instil-
lation of LPS or i.p. infection with E. coli and treatment with 
G-CSF antibody. Protein concentration was measured in the 
BALF using a protein assay reagent (Bio-Rad Laboratories). 
The standard curve was constructed using BSA (Su et al., 2008).
Neutrophil depletion with Gr-1 antibody
Neutrophil depletion was achieved by i.p. injection of 200 
µg/kg anti-Gr1 mAb RB6-8C5. The antibody was admin-
istered i.p. to obtain a sustained depletion over the first 48 h 
of the experiment. Differential white blood cell count using 
Wright–Giemsa staining was performed to confirm that the 
neutrophil depletion was successful. Neutrophils were de-
pleted by the Gr-1 antibody in both PB (∼85% depletion) 
and the BM (∼65% depletion; Kwak et al., 2015).
Histopathology
Lungs were collected after indicated treatment and fixed by 
intratracheal instillation of Bouin’s solution at 23-cm H2O 
pressure. Tissues were embedded in paraffin, and 6-µm–thick 
sections were stained with hematoxylin and eosin and ex-
amined by light microscopy. The number of neutrophils in 
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alveolar air spaces was quantified by morphometric analyses 
of histological lung sections as previously described (Mizgerd 
et al., 2000). ImageJ software (National Institutes of Health) 
was used to manually trace the neutrophil-containing regions 
of the tissue section and to determine the area of edema. The 
pixel area of each region was calculated. The neutrophil num-
ber was calculated as the total number of neutrophils out-
side the blood vessels in a given randomly chosen region. 
The edema formation was calculated as the percentage of 
pixel area of all the edema-containing regions relative to the 
pixel area of the whole image. The relative volumes of the 
parenchymal regions occupied by emigrated neutrophils and 
the level edema formation were calculated by investigators 
blinded to the identities of the mice.
Statistics
Results are presented as means with error bars indicating 
SD. Differences between groups were tested with Stu-
dent’s t test unless noted otherwise. P-values <0.05 were 
considered statistically significant. Neutrophil counts in 
PB after E. coli administration were analyzed by one-way 
ANO VA–repeated measures followed by Dunnett's multi-
ple comparison test. Differences over time between groups 
were analyzed using multivariate ANO VA with measures 
repeated over time. Experimental group and time were 
the independent variables. All statistical tests and graph-
ics were made using Prism (GraphPad Software) or SPSS 
Statistics software (IBM).
Online supplemental material
Fig. S1 shows flow cytometry analysis of peritoneal cells after 
i.p. injections of E. coli. Video  1 shows intravital imaging 
of neutrophil mobilization from the BM to circulation in 
an untreated mouse. Video  2 shows intravital imaging of 
MIP-2–induced neutrophil mobilization from the BM to 
circulation. Video  3 shows intravital imaging of G-CSF–
induced neutrophil mobilization from the BM to circulation. 
Video  4 shows intravital imaging of MIP-2–induced 
neutrophil mobilization from the BM to circulation in a 
G-CSF–treated mouse. Video 5 shows chemotaxis of mouse 
neutrophils (untreated) in response to an MIP-2 gradient. 
Video  6 shows chemotaxis of G-CSF–treated mouse 
neutrophils in response to an MIP-2 gradient. Video 7 shows 
chemotaxis of mouse neutrophils in response to a G-CSF 
gradient. Video  8 shows chemotaxis of mouse neutrophils 
(untreated) in response to an fMLP gradient. Video  9 
shows chemotaxis of G-CSF–treated mouse neutrophils in 
response to an fMLP gradient. Video 10 shows chemotaxis 
of mouse neutrophils treated with G-CSF and JAK inhibitor 
INCB018424 in response to an MIP-2 gradient. Online 
supplemental material is available at http ://www .jem .org /
cgi /content /full /jem .20160393 /DC1.
ACK NOW LED GME NTS
The authors thank John Lucky, Li Chai, and John Manis for helpful discussions. 
 Y. Xu is supported by the grants from National Basic Research Program of China 
(2015CB964903 and 2012CB966403), National Natural Sciences Foundation of China 
(31271484 and 31471116), and Natural Science Foundation of Tianjin City (12JCZ 
DJC24600). H. Luo is supported by National Institutes of Health grants (R01AI103142, 
R01HL092020, and P01 HL095489) and a grant from FAM RI (CIA 123008). 
 The authors declare no competing financial interests.
Submitted: 16 March 2016
Accepted: 19 July 2016
REFERENCES
Anderlini, P., D. Przepiorka, R. Champlin, and M. Körbling. 1996. Biologic 
and clinical effects of granulocyte colony-stimulating factor in normal 
individuals. Blood. 88:2819–2825.
Bardoel, B.W., E.F. Kenny, G. Sollberger, and A. Zychlinsky. 2014. The 
balancing act of neutrophils. Cell Host Microbe. 15:526–536. http ://dx 
.doi .org /10 .1016 /j .chom .2014 .04 .011
Basu, S., A. Dunn, and A. Ward. 2002. G-CSF: function and modes of action 
(Review). Int. J. Mol. Med. 10:3–10.
Bendall, L.J., and K.F. Bradstock. 2014. G-CSF: From granulopoietic stimulant 
to bone marrow stem cell mobilizing agent. Cytokine Growth Factor Rev. 
25:355–367. http ://dx .doi .org /10 .1016 /j .cytogfr .2014 .07 .011
Bratton, D.L., and P.M. Henson. 2011. Neutrophil clearance: when the party 
is over, clean-up begins. Trends Immunol. 32:350–357. http ://dx .doi .org 
/10 .1016 /j .it .2011 .04 .009
Broxmeyer, H.E. 2008. Chemokines in hematopoiesis. Curr. Opin. Hematol. 
15:49–58. http ://dx .doi .org /10 .1097 /MOH .0b013e3282f29012
Broxmeyer, H.E., C.M. Orschell, D.W. Clapp, G. Hangoc, S. Cooper, P.A. 
Plett, W.C. Liles, X. Li, B. Graham-Evans, T.B. Campbell, et al. 2005. 
Rapid mobilization of murine and human hematopoietic stem and 
progenitor cells with AMD3100, a CXCR4 antagonist. J. Exp. Med. 
201:1307–1318. http ://dx .doi .org /10 .1084 /jem .20041385
Burdon, P.C., C. Martin, and S.M. Rankin. 2005. The CXC chemokine 
MIP-2 stimulates neutrophil mobilization from the rat bone marrow in 
a CD49d-dependent manner. Blood. 105:2543–2548. http ://dx .doi .org 
/10 .1182 /blood -2004 -08 -3193
Cheretakis, C., R. Leung, C.X. Sun, Y. Dror, and M. Glogauer. 2006. Timing 
of neutrophil tissue repopulation predicts restoration of innate immune 
protection in a murine bone marrow transplantation model. Blood. 
108:2821–2826. http ://dx .doi .org /10 .1182 /blood -2006 -04 -018184
Christopher, M.J., and D.C. Link. 2007. Regulation of neutrophil homeostasis. 
Curr. Opin. Hematol. 14:3–8. http ://dx .doi .org /10 .1097 /00062752 
-200701000 -00003
Chtanova, T., M. Schaeffer, S.J. Han, G.G. van Dooren, M. Nollmann, P. 
Herzmark, S.W. Chan, H. Satija, K. Camfield, H. Aaron, et al. 2008. 
Dynamics of neutrophil migration in lymph nodes during infection. 
Immunity. 29:487–496. http ://dx .doi .org /10 .1016 /j .immuni .2008 .07 
.012
Cornish, A.L., I.K. Campbell, B.S. McKenzie, S. Chatfield, and I.P. Wicks. 
2009. G-CSF and GM-CSF as therapeutic targets in rheumatoid 
arthritis. Nat. Rev. Rheumatol. 5:554–559. http ://dx .doi .org /10 .1038 /
nrrheum .2009 .178
Cottler-Fox, M.H., T. Lapidot, I. Petit, O. Kollet, J.F. DiPersio, D. Link, and S. 
Devine. 2003. Stem cell mobilization. Hematology (Am Soc Hematol Educ 
Program). 2003:419–437.
Dale, D.C. 2012. Twenty years of the colony-stimulating factors. Curr. Opin. 
Hematol. 19:1–2. http ://dx .doi .org /10 .1097 /MOH .0b013e32834e3c6e
Dale, D.C., A.A. Bolyard, M.L. Kelley, E.C. Westrup, V. Makaryan, A. Aprikyan, 
B. Wood, and F.J. Hsu. 2011. The CXCR4 antagonist plerixafor is a 
potential therapy for myelokathexis, WHIM syndrome. Blood. 118:4963–
4966. http ://dx .doi .org /10 .1182 /blood -2011 -06 -360586
o
n
 February 8, 2017
D
ow
nloaded from
 
Published August 22, 2016
Negative regulation of CXCR2 signaling by G-CSF | Bajrami et al.2016
Day, R.B., and D.C. Link. 2012. Regulation of neutrophil trafficking from 
the bone marrow. Cell. Mol. Life Sci. 69:1415–1423. http ://dx .doi .org 
/10 .1007 /s00018 -011 -0870 -8
DeJesus, C.E., J. Egen, M. Metzger, X. Alvarez, C.A. Combs, D. Malide, 
Z.X. Yu, X. Tian, and R.E. Donahue. 2011. Transient neutropenia after 
granulocyte-colony stimulating factor administration is associated 
with neutrophil accumulation in pulmonary vasculature. Exp. Hematol. 
39:142–150. http ://dx .doi .org /10 .1016 /j .exphem .2010 .11 .004
De La Luz Sierra, M., P. Gasperini, P.J. McCormick, J. Zhu, and G. Tosato. 
2007. Transcription factor Gfi-1 induced by G-CSF is a negative 
regulator of CXCR4 in myeloid cells. Blood. 110:2276–2285. http ://dx 
.doi .org /10 .1182 /blood -2007 -03 -081448
Devi, S., Y. Wang, W.K. Chew, R. Lima, N. A-González, C.N. Mattar, S.Z. 
Chong, A. Schlitzer, N. Bakocevic, S. Chew, et al. 2013. Neutrophil 
mobilization via plerixafor-mediated CXCR4 inhibition arises from lung 
demargination and blockade of neutrophil homing to the bone marrow. 
J. Exp. Med. 210:2321–2336. http ://dx .doi .org /10 .1084 /jem .20130056
Doerschuk, C.M. 2000. Leukocyte trafficking in alveoli and airway passages. 
Respir. Res. 1:136–140. http ://dx .doi .org /10 .1186 /rr24
Doerschuk, C.M., M.F. Allard, S. Lee, M.L. Brumwell, and J.C. Hogg. 1988. 
Effect of epinephrine on neutrophil kinetics in rabbit lungs. J. Appl. 
Physiol. 65:401–407.
Donahue, R.E., L. Tuschong, T.R. Bauer Jr., Y.Y. Yau, S.F. Leitman, and 
D.D. Hickstein. 2011. Leukocyte integrin activation mediates transient 
neutropenia after G-CSF administration. Blood. 118:4209–4214. http ://
dx .doi .org /10 .1182 /blood -2011 -06 -360461
Eash, K.J., J.M. Means, D.W. White, and D.C. Link. 2009. CXCR4 is a key 
regulator of neutrophil release from the bone marrow under basal and 
stress granulopoiesis conditions. Blood. 113:4711–4719. http ://dx .doi 
.org /10 .1182 /blood -2008 -09 -177287
Eash, K.J., A.M. Greenbaum, P.K. Gopalan, and D.C. Link. 2010. CXCR2 
and CXCR4 antagonistically regulate neutrophil trafficking from 
murine bone marrow. J. Clin. Invest. 120:2423–2431. http ://dx .doi .org 
/10 .1172 /JCI41649
Eyles, J.L., M.J. Hickey, M.U. Norman, B.A. Croker, A.W. Roberts, S.F. Drake, 
W.G. James, D. Metcalf, I.K. Campbell, and I.P. Wicks. 2008. A key 
role for G-CSF-induced neutrophil production and trafficking during 
inflammatory arthritis. Blood. 112:5193–5201. http ://dx .doi .org /10 
.1182 /blood -2008 -02 -139535
Faust, N., F. Varas, L.M. Kelly, S. Heck, and T. Graf. 2000. Insertion of enhanced 
green fluorescent protein into the lysozyme gene creates mice with 
green fluorescent granulocytes and macrophages. Blood. 96:719–726.
Fibbe, W.E., J.F. Pruijt, G.A. Velders, G. Opdenakker, Y. van Kooyk, C.G. 
Figdor, and R. Willemze. 1999. Biology of IL-8-induced stem cell 
mobilization. Ann. N. Y. Acad. Sci. 872:71–82. http ://dx .doi .org /10 .1111 
/j .1749 -6632 .1999 .tb08454 .x
Foxman, E.F., J.J. Campbell, and E.C. Butcher. 1997. Multistep navigation 
and the combinatorial control of leukocyte chemotaxis. J. Cell Biol. 
139:1349–1360. http ://dx .doi .org /10 .1083 /jcb .139 .5 .1349
Furze, R.C., and S.M. Rankin. 2008. Neutrophil mobilization and clearance 
in the bone marrow. Immunology. 125:281–288. http ://dx .doi .org /10 
.1111 /j .1365 -2567 .2008 .02950 .x
Gordon, B.C., A.M. Revenis, A.C. Bonifacino, W.E. Sander, M.E. Metzger, 
A.E. Krouse, T.N. Usherson, and R.E. Donahue. 2007. Paradoxical 
drop in circulating neutrophil count following granulocyte-colony 
stimulating factor and stem cell factor administration in rhesus macaques. 
Exp. Hematol. 35:872–878. http ://dx .doi .org /10 .1016 /j .exphem .2007 
.03 .011
Greenbaum, A.M., and D.C. Link. 2011. Mechanisms of G-CSF-mediated 
hematopoietic stem and progenitor mobilization. Leukemia. 25:211–217. 
http ://dx .doi .org /10 .1038 /leu .2010 .248
Gregory, A.D., L.A. Hogue, T.W. Ferkol, and D.C. Link. 2007. Regulation of 
systemic and local neutrophil responses by G-CSF during pulmonary 
Pseudomonas aeruginosa infection. Blood. 109:3235–3243. http ://dx 
.doi .org /10 .1182 /blood -2005 -01 -015081
Heissig, B., K. Hattori, S. Dias, M. Friedrich, B. Ferris, N.R. Hackett, R.G. 
Crystal, P. Besmer, D. Lyden, M.A. Moore, et al. 2002. Recruitment of 
stem and progenitor cells from the bone marrow niche requires MMP-9 
mediated release of kit-ligand. Cell. 109:625–637. http ://dx .doi .org /10 
.1016 /S0092 -8674(02)00754 -7
Heit, B., S. Tavener, E. Raharjo, and P. Kubes. 2002. An intracellular signaling 
hierarchy determines direction of migration in opposing chemotactic 
gradients. J. Cell Biol. 159:91–102. http ://dx .doi .org /10 .1083 /jcb 
.200202114
Heit, B., S.M. Robbins, C.M. Downey, Z. Guan, P. Colarusso, B.J. Miller, F.R. 
Jirik, and P. Kubes. 2008. PTEN functions to ‘prioritize’ chemotactic 
cues and prevent ‘distraction’ in migrating neutrophils. Nat. Immunol. 
9:743–752. http ://dx .doi .org /10 .1038 /ni .1623
Karzai, W., B.U. von Specht, C. Parent, J. Haberstroh, K. Wollersen, C. 
Natanson, S.M. Banks, and P.Q. Eichacker. 1999. G-CSF during 
Escherichia coli versus Staphylococcus aureus pneumonia in rats has 
fundamentally different and opposite effects. Am. J. Respir. Crit. Care Med. 
159:1377–1382. http ://dx .doi .org /10 .1164 /ajrccm .159 .5 .9806082
Kim, H.K., M. De La Luz Sierra, C.K. Williams, A.V. Gulino, and G. Tosato. 
2006. G-CSF down-regulation of CXCR4 expression identified as a 
mechanism for mobilization of myeloid cells. Blood. 108:812–820. http 
://dx .doi .org /10 .1182 /blood -2005 -10 -4162
Knudsen, E., P.O. Iversen, A. Bøyum, T. Seierstad, G. Nicolaysen, and H.B. 
Benestad. 2011. G-CSF enhances the proliferation and mobilization, 
but not the maturation rate, of murine myeloid cells. Eur. J. Haematol. 
87:302–311. http ://dx .doi .org /10 .1111 /j .1600 -0609 .2011 .01658 .x
Köhler, A., K. De Filippo, M. Hasenberg, C. van den Brandt, E. Nye, M.P. 
Hosking, T.E. Lane, L. Männ, R.M. Ransohoff, A.E. Hauser, et al. 2011. 
G-CSF-mediated thrombopoietin release triggers neutrophil motility and 
mobilization from bone marrow via induction of Cxcr2 ligands. Blood. 
117:4349–4357. http ://dx .doi .org /10 .1182 /blood -2010 -09 -308387
Kondo, M., A.J. Wagers, M.G. Manz, S.S. Prohaska, D.C. Scherer, G.F. Beilhack, 
J.A. Shizuru, and I.L. Weissman. 2003. Biology of hematopoietic stem 
cells and progenitors: implications for clinical application. Annu. Rev. 
Immunol. 21:759–806. http ://dx .doi .org /10 .1146 /annurev .immunol .21 
.120601 .141007
Kruger, P., M. Saffarzadeh, A.N. Weber, N. Rieber, M. Radsak, H. von Bernuth, 
C. Benarafa, D. Roos, J. Skokowa, and D. Hartl. 2015. Neutrophils: 
Between host defence, immune modulation, and tissue injury. PLoS 
Pathog. 11:e1004651. http ://dx .doi .org /10 .1371 /journal .ppat .1004651
Kwak, H.J., P. Liu, B. Bajrami, Y. Xu, S.Y. Park, C. Nombela-Arrieta, S. Mondal, 
Y. Sun, H. Zhu, L. Chai, et al. 2015. Myeloid cell-derived reactive oxygen 
species externally regulate the proliferation of myeloid progenitors in 
emergency granulopoiesis. Immunity. 42:159–171. http ://dx .doi .org /10 
.1016 /j .immuni .2014 .12 .017
Leveque-El Mouttie, L., T. Vu, K.E. Lineburg, R.D. Kuns, F.O. Bagger, B.E. 
Teal, M. Lor, G.M. Boyle, C. Bruedigam, J.D. Mintern, et al. 2015. 
Autophagy is required for stem cell mobilization by G-CSF. Blood. 
125:2933–2936. http ://dx .doi .org /10 .1182 /blood -2014 -03 -562660
Levesque, J.P., F. Liu, P.J. Simmons, T. Betsuyaku, R.M. Senior, C. Pham, 
and D.C. Link. 2004. Characterization of hematopoietic progenitor 
mobilization in protease-deficient mice. Blood. 104:65–72. http ://dx .doi 
.org /10 .1182 /blood -2003 -05 -1589
Lévesque, J.P., J. Hendy, Y. Takamatsu, P.J. Simmons, and L.J. Bendall. 
2003. Disruption of the CXCR4/CXCL12 chemotactic interaction 
during hematopoietic stem cell mobilization induced by GCSF or 
cyclophosphamide. J. Clin. Invest. 111:187–196. http ://dx .doi .org /10 
.1172 /JCI15994
o
n
 February 8, 2017
D
ow
nloaded from
 
Published August 22, 2016
2017JEM Vol. 213, No. 10
Li, Y., Y. Jia, M. Pichavant, F. Loison, B. Sarraj, A. Kasorn, J. You, B.E. Robson, 
D.T. Umetsu, J.P. Mizgerd, et al. 2009. Targeted deletion of tumor 
suppressor PTEN augments neutrophil function and enhances host 
defense in neutropenia-associated pneumonia. Blood. 113:4930–4941. 
http ://dx .doi .org /10 .1182 /blood -2008 -06 -161414
Li, Y., A. Prasad, Y. Jia, S.G. Roy, F. Loison, S. Mondal, P. Kocjan, L.E. Silberstein, 
S. Ding, and H.R. Luo. 2011. Pretreatment with phosphatase and 
tensin homolog deleted on chromosome 10 (PTEN) inhibitor SF1670 
augments the efficacy of granulocyte transfusion in a clinically relevant 
mouse model. Blood. 117:6702–6713. http ://dx .doi .org /10 .1182 /blood 
-2010 -09 -309864
Liu, F., H.Y. Wu, R. Wesselschmidt, T. Kornaga, and D.C. Link. 1996. Impaired 
production and increased apoptosis of neutrophils in granulocyte 
colony-stimulating factor receptor-deficient mice. Immunity. 5:491–501. 
http ://dx .doi .org /10 .1016 /S1074 -7613(00)80504 -X
Liu, L., K.D. Puri, J.M. Penninger, and P. Kubes. 2007. Leukocyte PI3Kγ 
and PI3Kδ have temporally distinct roles for leukocyte recruitment in 
vivo. Blood. 110:1191–1198. http ://dx .doi .org /10 .1182 /blood -2006 -11 
-060103
Martin, C., P.C. Burdon, G. Bridger, J.C. Gutierrez-Ramos, T.J. Williams, 
and S.M. Rankin. 2003. Chemokines acting via CXCR2 and CXCR4 
control the release of neutrophils from the bone marrow and their return 
following senescence. Immunity. 19:583–593. http ://dx .doi .org /10 .1016 
/S1074 -7613(03)00263 -2
Mazo, I.B., J.C. Gutierrez-Ramos, P.S. Frenette, R.O. Hynes, D.D. Wagner, 
and U.H. von Andrian. 1998. Hematopoietic progenitor cell rolling in 
bone marrow microvessels: parallel contributions by endothelial selectins 
and vascular cell adhesion molecule 1. J. Exp. Med. 188:465–474. http ://
dx .doi .org /10 .1084 /jem .188 .3 .465
McColl, S.R., and I. Clark-Lewis. 1999. Inhibition of murine neutrophil re-
cruitment in vivo by CXC chemokine receptor antagonists. J. Immunol. 
163:2829–2835.
McDermott, D.H., Q. Liu, J. Ulrick, N. Kwatemaa, S. Anaya-O’Brien, S.R. 
Penzak, J.O. Filho, D.A. Priel, C. Kelly, M. Garofalo, et al. 2011. The 
CXCR4 antagonist plerixafor corrects panleukopenia in patients with 
WHIM syndrome. Blood. 118:4957–4962. http ://dx .doi .org /10 .1182 /
blood -2011 -07 -368084
McDermott, D.H., Q. Liu, D. Velez, L. Lopez, S. Anaya-O’Brien, J. Ulrick, 
N. Kwatemaa, J. Starling, T.A. Fleisher, D.A. Priel, et al. 2014. A phase 1 
clinical trial of long-term, low-dose treatment of WHIM syndrome with 
the CXCR4 antagonist plerixafor. Blood. 123:2308–2316. http ://dx .doi 
.org /10 .1182 /blood -2013 -09 -527226
Mei, J., Y. Liu, N. Dai, C. Hoffmann, K.M. Hudock, P. Zhang, S.H. Guttentag, 
J.K. Kolls, P.M. Oliver, F.D. Bushman, and G.S. Worthen. 2012. Cxcr2 
and Cxcl5 regulate the IL-17/G-CSF axis and neutrophil homeostasis in 
mice. J. Clin. Invest. 122:974–986. http ://dx .doi .org /10 .1172 /JCI60588
Metcalf, D., L. Robb, A.R. Dunn, S. Mifsud, and L. Di Rago. 1996. Role 
of granulocyte-macrophage colony-stimulating factor and granulocyte 
colony-stimulating factor in the development of an acute neutrophil in-
flammatory response in mice. Blood. 88:3755–3764.
Mizgerd, J.P., J.J. Peschon, and C.M. Doerschuk. 2000. Roles of tumor 
necrosis factor receptor signaling during murine Escherichia coli 
pneumonia. Am. J. Respir. Cell Mol. Biol. 22:85–91. http ://dx .doi .org /10 
.1165 /ajrcmb .22 .1 .3733
Nagase, H., M. Miyamasu, M. Yamaguchi, M. Imanishi, N.H. Tsuno, K. 
Matsushima, K. Yamamoto, Y. Morita, and K. Hirai. 2002. Cytokine-
mediated regulation of CXCR4 expression in human neutrophils. J. 
Leukoc. Biol. 71:711–717.
Nauseef, W.M., and N. Borregaard. 2014. Neutrophils at work. Nat. Immunol. 
15:602–611. http ://dx .doi .org /10 .1038 /ni .2921
Pelus, L.M., and S. Fukuda. 2006. Peripheral blood stem cell mobilization: the 
CXCR2 ligand GROβ rapidly mobilizes hematopoietic stem cells with 
enhanced engraftment properties. Exp. Hematol. 34:1010–1020. http ://
dx .doi .org /10 .1016 /j .exphem .2006 .04 .004
Pelus, L.M., H. Bian, A.G. King, and S. Fukuda. 2004. Neutrophil-derived 
MMP-9 mediates synergistic mobilization of hematopoietic stem and 
progenitor cells by the combination of G-CSF and the chemokines 
GROβ/CXCL2 and GROβT/CXCL2Δ4. Blood. 103:110–119. http ://
dx .doi .org /10 .1182 /blood -2003 -04 -1115
Peters, N.C., J.G. Egen, N. Secundino, A. Debrabant, N. Kimblin, S. Kamhawi, 
P. Lawyer, M.P. Fay, R.N. Germain, and D. Sacks. 2008. In vivo imaging 
reveals an essential role for neutrophils in leishmaniasis transmitted by 
sand flies. Science. 321:970–974. http ://dx .doi .org /10 .1126 /science 
.1159194
Petit, I., M. Szyper-Kravitz, A. Nagler, M. Lahav, A. Peled, L. Habler, T. 
Ponomaryov, R.S. Taichman, F. Arenzana-Seisdedos, N. Fujii, et al. 2002. 
G-CSF induces stem cell mobilization by decreasing bone marrow 
SDF-1 and up-regulating CXCR4. Nat. Immunol. 3:687–694. http ://dx 
.doi .org /10 .1038 /ni813
Petty, J.M., C.C. Lenox, D.J. Weiss, M.E. Poynter, and B.T. Suratt. 2009. 
Crosstalk between CXCR4/stromal derived factor-1 and VLA-4/
VCAM-1 pathways regulates neutrophil retention in the bone marrow. 
J. Immunol. 182:604–612. http ://dx .doi .org /10 .4049 /jimmunol .182 .1 
.604
Poon, I.K., C.D. Lucas, A.G. Rossi, and K.S. Ravichandran. 2014. Apoptotic 
cell clearance: basic biology and therapeutic potential. Nat. Rev. Immunol. 
14:166–180. http ://dx .doi .org /10 .1038 /nri3607
Sadik, C.D., N.D. Kim, and A.D. Luster. 2011. Neutrophils cascading their 
way to inflammation. Trends Immunol. 32:452–460. http ://dx .doi .org /10 
.1016 /j .it .2011 .06 .008
Semerad, C.L., F. Liu, A.D. Gregory, K. Stumpf, and D.C. Link. 2002. G-CSF 
is an essential regulator of neutrophil trafficking from the bone marrow 
to the blood. Immunity. 17:413–423. http ://dx .doi .org /10 .1016 /S1074 
-7613(02)00424 -7
Semerad, C.L., M.J. Christopher, F. Liu, B. Short, P.J. Simmons, I. Winkler, J.P. 
Levesque, J. Chappel, F.P. Ross, and D.C. Link. 2005. G-CSF potently 
inhibits osteoblast activity and CXCL12 mRNA expression in the bone 
marrow. Blood. 106:3020–3027. http ://dx .doi .org /10 .1182 /blood -2004 
-01 -0272
Smith, E., A. Zarbock, M.A. Stark, T.L. Burcin, A.C. Bruce, P. Foley, and K. 
Ley. 2007. IL-23 is required for neutrophil homeostasis in normal and 
neutrophilic mice. J. Immunol. 179:8274–8279. http ://dx .doi .org /10 
.4049 /jimmunol .179 .12 .8274
Stark, M.A., Y. Huo, T.L. Burcin, M.A. Morris, T.S. Olson, and K. Ley. 2005. 
Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 
and IL-17. Immunity. 22:285–294. http ://dx .doi .org /10 .1016 /j .immuni 
.2005 .01 .011
Strydom, N., and S.M. Rankin. 2013. Regulation of circulating neutrophil 
numbers under homeostasis and in disease. J. Innate Immun. 5:304–314. 
http ://dx .doi .org /10 .1159 /000350282
Su, X., M. Johansen, M.R. Looney, E.J. Brown, and M.A. Matthay. 2008. 
CD47 deficiency protects mice from lipopolysaccharide-induced acute 
lung injury and Escherichia coli pneumonia. J. Immunol. 180:6947–6953. 
http ://dx .doi .org /10 .4049 /jimmunol .180 .10 .6947
Subramanian, K.K., Y. Jia, D. Zhu, B.T. Simms, H. Jo, H. Hattori, J. You, J.P. 
Mizgerd, and H.R. Luo. 2007. Tumor suppressor PTEN is a physiologic 
suppressor of chemoattractant-mediated neutrophil functions. Blood. 
109:4028–4037. http ://dx .doi .org /10 .1182 /blood -2006 -10 -055319
Suratt, B.T., J.M. Petty, S.K. Young, K.C. Malcolm, J.G. Lieber, J.A. Nick, J.A. 
Gonzalo, P.M. Henson, and G.S. Worthen. 2004. Role of the CXCR4/
SDF-1 chemokine axis in circulating neutrophil homeostasis. Blood. 
104:565–571. http ://dx .doi .org /10 .1182 /blood -2003 -10 -3638
o
n
 February 8, 2017
D
ow
nloaded from
 
Published August 22, 2016
Negative regulation of CXCR2 signaling by G-CSF | Bajrami et al.2018
Vlahos, R., S. Bozinovski, S.P. Chan, S. Ivanov, A. Lindén, J.A. Hamilton, and 
G.P. Anderson. 2010. Neutralizing granulocyte/macrophage colony-
stimulating factor inhibits cigarette smoke-induced lung inflammation. 
Am. J. Respir. Crit. Care Med. 182:34–40. http ://dx .doi .org /10 .1164 /
rccm .200912 -1794OC
von Vietinghoff, S., and K. Ley. 2008. Homeostatic regulation of blood 
neutrophil counts. J. Immunol. 181:5183–5188. http ://dx .doi .org /10 
.4049 /jimmunol .181 .8 .5183
Wengner, A.M., S.C. Pitchford, R.C. Furze, and S.M. Rankin. 2008. 
The coordinated action of G-CSF and ELR + CXC chemokines in 
neutrophil mobilization during acute inflammation. Blood. 111:42–49. 
http ://dx .doi .org /10 .1182 /blood -2007 -07 -099648
Zhu, D., H. Hattori, H. Jo, Y. Jia, K.K. Subramanian, F. Loison, J. You, Y. Le, 
M. Honczarenko, L. Silberstein, and H.R. Luo. 2006. Deactivation 
of phosphatidylinositol 3,4,5-trisphosphate/Akt signaling mediates 
neutrophil spontaneous death. Proc. Natl. Acad. Sci. USA. 103:14836–
14841. http ://dx .doi .org /10 .1073 /pnas .0605722103
o
n
 February 8, 2017
D
ow
nloaded from
 
Published August 22, 2016
